Author

Martha Tsaliki

Institutions: Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center

Observed institutions: Oklahoma Medical Research Foundation, Oklahoma City VA Medical Center, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center

ORCID: 0000-0001-9615-6699

Observed ORCID: 0000-0001-9615-6699

OpenAlex ID: A5015526430

Ubiquitin‐binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer

2020 · Xunhao Xiong, Geeta Rao, et al. · The FASEB Journal · 13

Ovarian antibodies among SLE women with premature menopause after cyclophosphamide

2020 · Martha Tsaliki, Kristi A. Koelsch, et al. · International Journal of Rheumatic Diseases · 12

A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren’s disease

2025 · Martha Tsaliki, Joshua Cavett, et al. · Annals of the Rheumatic Diseases · 4

Experimental induction of anti-muscarinic type-3-receptor extracellular loop antibodies by immunization with 4-hydroxy-2-nonenal modified Ro60 and unmodified Ro60

2024 · Biji T Kurien, Devavrat Dave, et al. · Clinical & Experimental Immunology · 1

Muscarinic 3 receptor antibodies in Sjögren's disease: Evaluating assay variability and detection methods

2026 · Martha Tsaliki, Devavrat Dave, et al. · Journal of Immunological Methods

Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sjögren’s Disease

2025 · Martha Tsaliki, Biji T Kurien, et al. · International Journal of Molecular Sciences

Immunodiagnosis of Sjögren's Disease

2024 · R. Hal Scofield, Martha Tsaliki

266 Anti-ovarian antibodies are not found more commonly among SLE women with pre-mature menopause

2019 · Martha Tsaliki, Kristi A Koelsch, et al. · Abstracts

Works count: 8

Citation count: 30

H-index: 3

I10-index: 2